Skip to main content

Year: 2019

Nabriva Therapeutics Announces $20 Million Registered Direct Offering

DUBLIN, Ireland and KING OF PRUSSIA, Pa., Dec. 20, 2019 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced that it has entered into a definitive agreement with certain institutional investors for the purchase and sale in a registered direct offering of (i) an aggregate of 13,793,106 ordinary shares and (ii) warrants to purchase up to an aggregate of 13,793,106 ordinary shares.  Each ordinary share and accompanying warrant are being sold together at a combined purchase price of $1.45.  The warrants have an exercise price of $1.90 per share, are initially exercisable six months following issuance (the “Initial Exercise Date”) and will expire on...

Continue reading

Ascent Obtains Court Approval of CCAA Plan and Announces Bi-Weekly Default Status Report

VANCOUVER, British Columbia, Dec. 20, 2019 (GLOBE NEWSWIRE) — Ascent Industries Corp. (CSE: ASNT) (“Ascent” or the “Company”) is pleased to announce that the Company and certain of its affiliates obtained an order of the Supreme Court of British Columbia (the “Court”) sanctioning and approving the Company’s first amended and restated consolidated plan of compromise, arrangement and organization (the “Plan”) under the Companies’ Creditors Arrangement Act (“CCAA”) at a hearing held on December 19, 2019.The Court’s sanction and approval of the Plan represents a key step towards the Company’s implementation of the Plan. The Company is now diligently working towards satisfying the remaining conditions precedents to the Plan. The Company currently anticipates...

Continue reading

TCG BDC, Inc. Declares Special Dividend of $0.18 per Share

NEW YORK, Dec. 20, 2019 (GLOBE NEWSWIRE) — TCG BDC, Inc. (together with its consolidated subsidiaries, “we,” “us,” “our,” “TCG BDC” or the “Company”) (NASDAQ: CGBD) today announced that its Board of Directors declared a special dividend of $0.18 per share, which is payable on January 17, 2020 to stockholders of record as of December 31, 2019.About TCG BDC, Inc.TCG BDC is an externally managed specialty finance company focused on lending to middle-market companies. TCG BDC is managed by Carlyle Global Credit Investment Management L.L.C., an SEC-registered investment adviser and a wholly owned subsidiary of The Carlyle Group L.P. Since it commenced investment operations in May 2013 through September 30, 2019, TCG BDC has invested approximately $5.3 billion in...

Continue reading

AGF Management Limited Declares Fourth Quarter 2019 Dividend

TORONTO, Dec. 20, 2019 (GLOBE NEWSWIRE) — On December 18, 2019, the Board of Directors of AGF Management Limited declared a dividend of $0.08 per share on both the Class B Non-Voting shares and the Class A Voting common shares of the company. This dividend will be payable on January 16, 2020 to shareholders of record on January 8, 2020.ABOUT AGF MANAGEMENT LIMITEDFounded in 1957, AGF Management Limited (AGF) is an independent and globally diverse asset management firm. AGF brings a disciplined approach to delivering excellence in investment management through its fundamental, quantitative, alternative and high-net-worth businesses focused on providing an exceptional client experience. AGF’s suite of investment solutions extends globally to a wide range of clients, from financial advisors and individual investors to institutional...

Continue reading

La Société de Gestion AGF Limitée déclare un dividende pour le quatrième trimestre de 2019

TORONTO, 20 déc. 2019 (GLOBE NEWSWIRE) — Le 18 décembre 2019, le conseil d’administration de La Société de Gestion AGF Limitée a déclaré un dividende de 0,08 $ par action pour les actions de catégorie B sans droit de vote et pour les actions ordinaires de catégorie A avec droit de vote de la Société. Ce dividende sera payable le 16 janvier 2020 aux actionnaires inscrits au 8 janvier 2020.AU SUJET DE LA SOCIÉTÉ DE GESTION AGF LIMITÉEFondée en 1957, La Société de Gestion AGF Limitée (AGF) est une société indépendante de gestion de placements diversifiés à l’échelle mondiale. AGF apporte de la discipline en offrant l’excellence...

Continue reading

Investors House Oyj: johtohenkilöiden liiketoimet

Investors House Oyj – Johdon liiketoimet____________________________________________IlmoitusvelvollinenNimi: Rautiainen TapaniAsema: Hallituksen jäsen/varajäsenLiikkeeseenlaskija: Investors House OyjLEI: 74370058ZYOB0GIYUT38Ilmoituksen luonne: ENSIMMÄINEN ILMOITUSViitenumero: 74370058ZYOB0GIYUT38_20191220132322_2____________________________________________Liiketoimen päivämäärä: 2019-12-20Kauppapaikka ei sovelluInstrumenttityyppi: OSAKEISIN: FI0009900559Liiketoimen luonne: OSAKEPALKKION VASTAANOTTAMINEN

Continue reading

Abeona Therapeutics Receives European Medicines Agency PRIME Designation for ABO-102 Gene Therapy in MPS IIIA

NEW YORK and CLEVELAND, Dec. 20, 2019 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that the European Medicines Agency (EMA) has granted Priority Medicines (PRIME) designation to the Company’s ABO-102 program studying its adeno-associated virus 9 (AAV9) gene therapy for Sanfilippo syndrome type A (MPS IIIA). The PRIME designation is based on nonclinical data and clinical data from the Transpher A Study, a global Phase 1/2 clinical trial evaluating a single-dose of ABO-102 for the treatment of children with MPS IIIA.“EMA’s PRIME designation for the ABO-102 program recognizes the urgent need for a treatment option for children suffering from MPS IIIA, and underscores the potential of ABO-102 to modify the course of this devastating...

Continue reading

Investors House Oyj: johtohenkilöiden liiketoimet

Investors House Oyj – Johdon liiketoimet____________________________________________IlmoitusvelvollinenNimi: Komulainen PekkaAsema: Hallituksen jäsen/varajäsenLiikkeeseenlaskija: Investors House OyjLEI: 74370058ZYOB0GIYUT38Ilmoituksen luonne: ENSIMMÄINEN ILMOITUSViitenumero: 74370058ZYOB0GIYUT38_20191220132643_4____________________________________________Liiketoimen päivämäärä: 2019-12-20Kauppapaikka ei sovelluInstrumenttityyppi: OSAKEISIN: FI0009900559Liiketoimen luonne: OSAKEPALKKION VASTAANOTTAMINEN

Continue reading

Investors House Oyj: johtohenkilöiden liiketoimet

Investors House Oyj – Johdon liiketoimet____________________________________________IlmoitusvelvollinenNimi: Grönroos MikaelAsema: Hallituksen jäsen/varajäsenLiikkeeseenlaskija: Investors House OyjLEI: 74370058ZYOB0GIYUT38Ilmoituksen luonne: ENSIMMÄINEN ILMOITUSViitenumero: 74370058ZYOB0GIYUT38_20191220132524_3____________________________________________Liiketoimen päivämäärä: 2019-12-20Kauppapaikka ei sovelluInstrumenttityyppi: OSAKEISIN: FI0009900559Liiketoimen luonne: OSAKEPALKKION VASTAANOTTAMINEN

Continue reading

Konsolidator får første kunde på det store tyske marked

Selskabsmeddelelse nr. 8-2019Konsolidator har indgået aftale med den første tyske kunde. Åbningen af det tyske marked er en vigtig milepæl for Konsolidator og en integreret del af Konsolidators vækststrategi. Til understøttelse af den forventede vækst er Konsolidator i dialog med førende revisionshuse, der kan onboarde kunder på det tyske marked.CEO, Claus Finderup Grove, udtaler: “Med vores første kunde på det tyske marked bekræftes vores antagelser, at der også i Tyskland er et marked og en efterspørgsel på den service vi leverer med Konsolidator.”Om Konsolidator

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.